Research Topics
Species | Francis LeviSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
The circadian timing system: a coordinator of life processes: chronobiological investigations. Implications for the rhythmic delivery of cancer therapeuticsFrancis A Lévi
U 776 INSERM, Rythmes Biologiques et Cancers, Hopital Paul Brousse, Villejuif, France
IEEE Eng Med Biol Mag 27:17-9. 2008
Chronotherapeutics: the relevance of timing in cancer therapyFrancis Levi
INSERM E0354 Chronothérapeutique des cancers, Hôpital Paul Brousse I C I G, 94807 Villejuif Cedex, France
Cancer Causes Control 17:611-21. 2006..This circadian organization is responsible for predictable changes in the tolerability and efficacy of anticancer agents, and possibly also in tumor promotion or growth...
Sex and dosing-time dependencies in irinotecan-induced circadian disruptionConstance Ahowesso
INSERM, UMRS 776 Rythmes biologique et cancers, Hopital Paul Brousse, Villejuif, France
Chronobiol Int 28:458-70. 2011..Thus, the optimal circadian timing of chemotherapy requires precise determination according to sex, and should involve the noninvasive monitoring of circadian biomarkers...
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectabilityFrancis Levi
INSERM, U776 Rythmes biologiques et cancers, Hopital Paul Brousse, 14 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
Cancer Chemother Pharmacol 67:339-48. 2011..We hypothesized that EGFR blockade with cetuximab would enhance the activity of chronotherapy as a result of improved circadian coordination...
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963)Pasquale F Innominato
INSERM, U776, Biological Rhythms and Cancers, Villejuif, France
Chronobiol Int 28:586-600. 2011..The opposite trend shown here for chronoFLO4 supports the novel concept of jointly optimized hematologic tolerability and efficacy through personalized circadian-timed therapy...
Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastasesDennis A Wicherts
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Ann Surg Oncol 18:659-69. 2011..The goal was to evaluate its incidence and impact on the outcome of patients resected for colorectal liver metastases (CLM)...
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastasesRobbert J de Haas
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Ann Surg Oncol 17:1010-23. 2010....
Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancerMohamed Bouchahda
Chronotherapy Unit, Medical Oncology Department, Hepatobiliary Center, Public Assistance Hospital of Paris, Paul Brousse Hospital, Villejuif, France
Cancer 115:4990-9. 2009..In this article, the authors report their experience with chronomodulated HAI chemotherapy as rescue therapy in heavily pretreated patients who had metastatic colorectal cancer...
Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timingXiao Mei Li
INSERM U776, Rythmes Biologiques et Cancers, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Unité de Chronothérapie, Departement d Oncologie Medicale, Hopital Paul Brousse, Villejuif, France
Cancer Res 70:3351-60. 2010..Targeting circadian clocks represents a novel potential challenge for cancer therapeutics...
Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileumAlper Okyar
INSERM, U776 Rythmes biologiques et cancers, Hopital Paul Brousse, Villejuif, France
PLoS ONE 6:e20393. 2011..Here, we investigate whether circadian changes in local abcc2 expression participate in the circadian rhythm of irinotecan toxicity for ileum mucosa, and further assess whether genetic background or sex modify this relation...
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosisMohamed Bouchahda
Chronotherapy Unit and Department of Medical Oncology, Assistance Publique Hopitaux de Paris, Villejuif, France
Cancer Chemother Pharmacol 66:605-9. 2010..We report the first case of multiple KRAS mutations acquired during the metastatic phase of CRC, and retrospectively reviewed all patients with CRC, in whom KRAS was analyzed in at least two tumor samples from distinct lesions...
Circadian timing in cancer treatmentsFrancis Levi
INSERM, U Rythmes Biologiques et Cancers, Hopital Paul Brousse, Villejuif, France
Annu Rev Pharmacol Toxicol 50:377-421. 2010..Mathematical and systems biology approaches currently develop and integrate theoretical, experimental, and technological tools in order to further optimize and personalize the circadian administration of cancer treatments...
Effects of light and food schedules on liver and tumor molecular clocks in miceElisabeth Filipski
, , 94807 Villejuif Cedex, France
J Natl Cancer Inst 97:507-17. 2005..CONCLUSIONS: Altered light-dark or feeding schedules modified the expression of molecular clock genes and genes involved in carcinogenesis and tumor progression...
Disruption of circadian coordination accelerates malignant growth in miceElisabeth Filipski
, , 94800, Villejuif, France
Pathol Biol (Paris) 51:216-9. 2003..This shows that disruption of circadian coordination accelerates malignant growth in mice, suggesting that the host circadian clock controls tumor progression...
Host circadian clock as a control point in tumor progressionElisabeth Filipski
, Equipe Propre INSERM 0118 Cancer chronotherapeutics, , Paul Brousse Hospital, Villejuif, France
J Natl Cancer Inst 94:690-7. 2002..CONCLUSIONS: Disruption of circadian rhythms in mice was associated with accelerated growth of malignant tumors of two types, suggesting that the host circadian clock may play an important role in endogenous control of tumor progression...
Circadian disruption accelerates liver carcinogenesis in miceElisabeth Filipski
INSERM, U776 Rythmes biologiques et cancers, Hopital Paul Brousse, Villejuif F 94807, France
Mutat Res 680:95-105. 2009..Here, we investigate the role of CJL as a tumor promoter in mice exposed to the hepatic carcinogen, diethylnitrosamine (DEN)...
From circadian rhythms to cancer chronotherapeuticsFrancis Levi
INSERM EPI 0118 Cancer Chronotherapeutics, Université Paris XI and Chronotherapy Group, European Organisation for Research and Treatment of Cancer, Hĵpital Paul Brousse, Villejuif, France
Chronobiol Int 19:1-19. 2002..It is conducting currently six trials and preparing four new studies. The 19 contributions in this special issue reflect the current status and perspectives of the several components of cancer chronotherapeutics...
Circadian disruption in experimental cancer processesElisabeth Filipski
Hopital Paul Brousse, Villejuif, France
Integr Cancer Ther 8:298-302. 2009..These results support the role of the CTS in cancer progression and call for the development of therapeutic strategies aimed at preventing or treating circadian clock dysfunctions...
Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumorTeresa G Granda
Cancer Chronotherapeutics, , , Villejuif, France
FASEB J 19:304-6. 2005..Conversely, a molecular circadian clock likely regulated BCL-2 and BAX expression in the bone marrow, increasing cellular protection against apoptosis during the rest span...
Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancerDany Gholam
INSERM U776 Rythmes Biologiques et Cancers, , Villejuif, France
Oncologist 11:1072-80. 2006..CONCLUSIONS: ChronoIFLO safely and durably halted tumor progression in most extensively pretreated MCRC patients...
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancerPasquale F Innominato
INSERM, U776 Biological Rhythms and Cancers, Villejuif, France
Cancer Res 69:4700-7. 2009..The circadian timing system constitutes a novel therapeutic target. Interventions that normalize circadian timing system dysfunction may affect quality of life and survival in cancer patients...
Circadian rhythms: mechanisms and therapeutic implicationsFrancis Levi
INSERM U776, Unité de Chronothérapie, Service de cancérologie, Hôpital Paul Brousse et Université Paris XI, 94800 Villejuif, France
Annu Rev Pharmacol Toxicol 47:593-628. 2007..This knowledge can in turn be used in improving or designing chronotherapeutics for the patients who suffer from many of the major human diseases...
Implications of circadian clocks for the rhythmic delivery of cancer therapeuticsFrancis Levi
INSERM, U776 Rythmes biologiques et cancers, Villejuif 94807, France
Philos Trans A Math Phys Eng Sci 366:3575-98. 2008..The models showed that additional therapeutic strategy further sets the constraints for the identification of the most effective chronomodulated schedules...
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of CanSylvie Giacchetti
Hopital Paul Brousse and INSERM, Villejuif, France
J Clin Oncol 24:3562-9. 2006..The strong sex dependency of optimal scheduling of fluorouracil, leucovorin, and oxaliplatin calls for translational investigations of determinants related to the patient's molecular clock...
Circadian rhythm of irinotecan tolerability in miceElisabeth Filipski
INSERM E0354 Cancer Chronotherapeutics, , Paul Brousse Hospital, Villejuif, France
Chronobiol Int 21:613-30. 2004..The results support the administration of CPT-11 to cancer patients in the second half of the night, during sleep, in order to improve drug tolerability...
Tumor-based rhythms of anticancer efficacy in experimental modelsTeresa G Granda
INSERM EPI 0118 Cancer Chronotherapeutics, , Hĵpital Paul Brousse, Villejuif, France
Chronobiol Int 19:21-41. 2002..Results of laboratory animal studies have been extrapolated to the design of clinical cancer therapy trials involving a chronobiological approach...
Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclibIda Iurisci
INSERM, U 776 Rythmes biologiques et cancers, Hôp P Brousse, Villejuif, F 94807, France
Chronobiol Int 26:1169-88. 2009..Modifications of cell cycle gene expression in the liver likely involve other mechanisms. Circadian clocks represent relevant targets to consider for optimization of therapeutic schedules of CDK inhibitors...
Disruption of circadian coordination and malignant growthElizabeth Filipski
INSERM E 354 Cancer Chronotherapeutics, Hopital Paul Brousse, Villejuif, France
Cancer Causes Control 17:509-14. 2006..Conclusions:These results indicate that circadian system could play an important role in malignant growth control. This should be taken into consideration in cancer prevention and therapy...
Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitorIda Iurisci
, U776 Rythmes biologiques et cancers, , Villejuif Cedex, France
Cancer Res 66:10720-8. 2006..The coordination of clock gene expression patterns in tumor cells was associated with best antitumor activity of Seliciclib. The circadian clock and its upstream regulators represent relevant targets for CDKIs...
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastasesThomas Aloia
Department of Hepatobiliary Surgery and Liver Transplantation, Paul-Brousse Hospital, Villejuif, France
J Clin Oncol 24:4983-90. 2006..The risk for other postoperative complications is related to the duration of preoperative chemotherapy administration...
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?Rene Adam
AP HP Hopital Paul Brousse, Centre Hépato Biliaire and Department of Medical Oncology, Villejuif, France
J Clin Oncol 27:1829-35. 2009..The aim of this study was to evaluate long-term outcome after combining downsizing chemotherapy and rescue surgery and to define prognostic factors of cure...
Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in miceXiao Mei Li
INSERM EPI 0118 Cancer Chronotherapeutics, Universite Paris XI, Hĵpital Paul Brousse, Villejuif, France
Chronobiol Int 19:43-55. 2002..Our findings demonstrate that VRL can transiently, yet profoundly, alter circadian clock function. Vinorelbine-induced circadian dysfunction may contribute to the toxicokinetics of this and possibly other anticancer drugs...
Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance statusMarie-Christine Mormont
INSERM EPI 0118 Cancer Chronotherapeutics, , Hĵpital Paul Brousse, Villejuif, France
Chronobiol Int 19:141-55. 2002..Such 24h rhythm alterations appeared to be independent of conventional clinical factors...
[Rhythm of expression of BCL-2 protein of MA13/C mammaryadenocarcinoma bearing-mice]Teresa G Granda
Inserm E 0354, , Villejuif, France
Pathol Biol (Paris) 51:220-1. 2003..BCL-2 acrophase coincided with the time of highest docetaxel tolerability and efficacy in this model. This suggests that BCL-2 protects the bone marrow from the drug toxicity, especially during the light phase...
Implications of circadian clocks for the rhythmic delivery of cancer therapeuticsFrancis Levi
INSERM, U776 Rythmes biologiques et cancers, Hopital Paul Brousse, Villejuif, F 94807, France
Adv Drug Deliv Rev 59:1015-35. 2007....
Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeuticsFrancis Levi
Hopital Paul Brousse, INSERM, U776 Rythmes biologiques et cancers, Villejuif, F 94807, France
Expert Opin Drug Deliv 8:1535-41. 2011..Intelligent drug delivery systems could then integrate the critical rhythmic information stemming from the individual patient and achieve a critical leap forward in the safe administration of potentially toxic therapeutic agents...
Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcomeMarie-Christine Mormon
, Federation des Maladies Sanguines et Tumorales, Villejuif, France
Anticancer Res 22:1243-9. 2002..This study suggests that the clinical relevance of cortisol circadian rhythm for patient outcome may differ according to the hormonal dependency of the tumor...
[Circadian control of muscle transcriptome]Sandrine Dulong
Rythmes Biologiques et Cancers, , 14, avenue Paul Vaillant Couturier, 94807 Villejuif, France
Med Sci (Paris) 24:372-4. 2008
